nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—CYP2D6—Lomustine—brain cancer	0.123	0.253	CbGbCtD
Trazodone—CYP2D6—Hydroxyurea—brain cancer	0.0931	0.192	CbGbCtD
Trazodone—CYP3A4—Temozolomide—brain cancer	0.0919	0.19	CbGbCtD
Trazodone—CYP3A4—Lomustine—brain cancer	0.0781	0.161	CbGbCtD
Trazodone—CYP3A5—Etoposide—brain cancer	0.0484	0.0999	CbGbCtD
Trazodone—ABCB1—Etoposide—brain cancer	0.0315	0.065	CbGbCtD
Trazodone—HTR2C—choroid plexus—brain cancer	0.0228	0.123	CbGeAlD
Trazodone—CYP3A4—Etoposide—brain cancer	0.0189	0.039	CbGbCtD
Trazodone—HTR2A—choroid plexus—brain cancer	0.0114	0.0618	CbGeAlD
Trazodone—HRH1—nose—brain cancer	0.00882	0.0477	CbGeAlD
Trazodone—HTR2C—telencephalic ventricle—brain cancer	0.00667	0.0361	CbGeAlD
Trazodone—HTR2A—trigeminal nerve—brain cancer	0.00578	0.0313	CbGeAlD
Trazodone—HTR2A—cerebellar cortex—brain cancer	0.00576	0.0311	CbGeAlD
Trazodone—HTR1A—telencephalic ventricle—brain cancer	0.00562	0.0304	CbGeAlD
Trazodone—Trifluoperazine—S100A4—brain cancer	0.00548	0.794	CrCbGaD
Trazodone—HTR2A—vein—brain cancer	0.00522	0.0283	CbGeAlD
Trazodone—HTR2C—ganglion—brain cancer	0.00415	0.0225	CbGeAlD
Trazodone—HTR2A—cranial nerve—brain cancer	0.00412	0.0223	CbGeAlD
Trazodone—HTR2A—pons—brain cancer	0.00407	0.022	CbGeAlD
Trazodone—SLC6A4—ganglion—brain cancer	0.00394	0.0213	CbGeAlD
Trazodone—HTR1A—ganglion—brain cancer	0.0035	0.0189	CbGeAlD
Trazodone—HTR2A—telencephalic ventricle—brain cancer	0.00335	0.0181	CbGeAlD
Trazodone—SLC6A4—hindbrain—brain cancer	0.00299	0.0162	CbGeAlD
Trazodone—HTR2A—pineal body—brain cancer	0.0029	0.0157	CbGeAlD
Trazodone—HTR1A—hindbrain—brain cancer	0.00265	0.0143	CbGeAlD
Trazodone—ADRA1A—hindbrain—brain cancer	0.00244	0.0132	CbGeAlD
Trazodone—HTR2A—ganglion—brain cancer	0.00208	0.0113	CbGeAlD
Trazodone—HTR2C—brainstem—brain cancer	0.00181	0.00977	CbGeAlD
Trazodone—HTR2A—endothelium—brain cancer	0.0018	0.00972	CbGeAlD
Trazodone—CYP3A7—endocrine gland—brain cancer	0.00178	0.00962	CbGeAlD
Trazodone—SLC6A4—brainstem—brain cancer	0.00171	0.00926	CbGeAlD
Trazodone—HTR2A—blood vessel—brain cancer	0.00166	0.00897	CbGeAlD
Trazodone—HTR2C—telencephalon—brain cancer	0.0016	0.00867	CbGeAlD
Trazodone—HTR2A—hindbrain—brain cancer	0.00158	0.00855	CbGeAlD
Trazodone—HTR1A—brainstem—brain cancer	0.00152	0.00822	CbGeAlD
Trazodone—SLC6A4—telencephalon—brain cancer	0.00152	0.00822	CbGeAlD
Trazodone—HTR2B—telencephalon—brain cancer	0.00151	0.00814	CbGeAlD
Trazodone—Urinary incontinence—Carmustine—brain cancer	0.00148	0.00521	CcSEcCtD
Trazodone—CYP2D6—hindbrain—brain cancer	0.00144	0.00779	CbGeAlD
Trazodone—Depressed level of consciousness—Temozolomide—brain cancer	0.00143	0.00504	CcSEcCtD
Trazodone—Urinary incontinence—Temozolomide—brain cancer	0.00143	0.00504	CcSEcCtD
Trazodone—Numbness—Etoposide—brain cancer	0.00143	0.00503	CcSEcCtD
Trazodone—Pollakiuria—Procarbazine—brain cancer	0.00142	0.005	CcSEcCtD
Trazodone—ADRA1A—brainstem—brain cancer	0.0014	0.00758	CbGeAlD
Trazodone—Photosensitivity reaction—Procarbazine—brain cancer	0.0014	0.00494	CcSEcCtD
Trazodone—Apnoea—Etoposide—brain cancer	0.0014	0.00492	CcSEcCtD
Trazodone—Drowsiness—Procarbazine—brain cancer	0.00137	0.00483	CcSEcCtD
Trazodone—Sensory loss—Etoposide—brain cancer	0.00137	0.00482	CcSEcCtD
Trazodone—Dry eye—Temozolomide—brain cancer	0.00137	0.00482	CcSEcCtD
Trazodone—HTR1A—telencephalon—brain cancer	0.00135	0.0073	CbGeAlD
Trazodone—Pain—Carboplatin—brain cancer	0.00134	0.00474	CcSEcCtD
Trazodone—Jaundice—Procarbazine—brain cancer	0.00133	0.0047	CcSEcCtD
Trazodone—Mental disability—Carmustine—brain cancer	0.00133	0.00468	CcSEcCtD
Trazodone—Sweating—Procarbazine—brain cancer	0.00131	0.00463	CcSEcCtD
Trazodone—Anorexia—Lomustine—brain cancer	0.00131	0.00462	CcSEcCtD
Trazodone—Haematuria—Procarbazine—brain cancer	0.0013	0.0046	CcSEcCtD
Trazodone—Mental disability—Temozolomide—brain cancer	0.00128	0.00453	CcSEcCtD
Trazodone—HTR2C—medulla oblongata—brain cancer	0.00126	0.00681	CbGeAlD
Trazodone—ORM1—spinal cord—brain cancer	0.00125	0.00676	CbGeAlD
Trazodone—ADRA1A—telencephalon—brain cancer	0.00124	0.00673	CbGeAlD
Trazodone—Body temperature increased—Carboplatin—brain cancer	0.00124	0.00438	CcSEcCtD
Trazodone—Eye pain—Carmustine—brain cancer	0.00123	0.00434	CcSEcCtD
Trazodone—Hallucination—Procarbazine—brain cancer	0.00122	0.00431	CcSEcCtD
Trazodone—Deafness—Temozolomide—brain cancer	0.0012	0.00423	CcSEcCtD
Trazodone—Decreased appetite—Lomustine—brain cancer	0.00119	0.00421	CcSEcCtD
Trazodone—Eye pain—Temozolomide—brain cancer	0.00119	0.00419	CcSEcCtD
Trazodone—Amnesia—Carmustine—brain cancer	0.00118	0.00417	CcSEcCtD
Trazodone—Nasal congestion—Temozolomide—brain cancer	0.00118	0.00416	CcSEcCtD
Trazodone—HTR2C—midbrain—brain cancer	0.00115	0.00623	CbGeAlD
Trazodone—Amnesia—Temozolomide—brain cancer	0.00114	0.00403	CcSEcCtD
Trazodone—Flushing—Procarbazine—brain cancer	0.00114	0.00402	CcSEcCtD
Trazodone—ORM1—endocrine gland—brain cancer	0.00112	0.00608	CbGeAlD
Trazodone—HTR2C—spinal cord—brain cancer	0.00112	0.00607	CbGeAlD
Trazodone—Hyponatraemia—Carmustine—brain cancer	0.00111	0.00393	CcSEcCtD
Trazodone—Diplopia—Carmustine—brain cancer	0.00111	0.00392	CcSEcCtD
Trazodone—Chills—Procarbazine—brain cancer	0.0011	0.00389	CcSEcCtD
Trazodone—Arrhythmia—Procarbazine—brain cancer	0.0011	0.00387	CcSEcCtD
Trazodone—SLC6A4—midbrain—brain cancer	0.00109	0.0059	CbGeAlD
Trazodone—ABCB1—blood vessel—brain cancer	0.00109	0.00588	CbGeAlD
Trazodone—Body temperature increased—Lomustine—brain cancer	0.00109	0.00383	CcSEcCtD
Trazodone—Alopecia—Procarbazine—brain cancer	0.00108	0.00383	CcSEcCtD
Trazodone—Weight increased—Hydroxyurea—brain cancer	0.00108	0.00381	CcSEcCtD
Trazodone—Diplopia—Temozolomide—brain cancer	0.00107	0.00379	CcSEcCtD
Trazodone—SLC6A4—spinal cord—brain cancer	0.00106	0.00576	CbGeAlD
Trazodone—Drowsiness—Hydroxyurea—brain cancer	0.00106	0.00373	CcSEcCtD
Trazodone—Tension—Procarbazine—brain cancer	0.00105	0.0037	CcSEcCtD
Trazodone—Ataxia—Carmustine—brain cancer	0.00104	0.00368	CcSEcCtD
Trazodone—Nervousness—Procarbazine—brain cancer	0.00104	0.00366	CcSEcCtD
Trazodone—ORM1—central nervous system—brain cancer	0.00101	0.00548	CbGeAlD
Trazodone—Ataxia—Temozolomide—brain cancer	0.00101	0.00356	CcSEcCtD
Trazodone—Tremor—Procarbazine—brain cancer	0.001	0.00353	CcSEcCtD
Trazodone—HTR2C—head—brain cancer	0.000998	0.0054	CbGeAlD
Trazodone—Anaemia—Procarbazine—brain cancer	0.000988	0.00349	CcSEcCtD
Trazodone—HTR1A—midbrain—brain cancer	0.000969	0.00524	CbGeAlD
Trazodone—HRH1—telencephalon—brain cancer	0.000963	0.00521	CbGeAlD
Trazodone—SLC6A4—endocrine gland—brain cancer	0.000958	0.00518	CbGeAlD
Trazodone—Syncope—Procarbazine—brain cancer	0.000958	0.00338	CcSEcCtD
Trazodone—Cardiac failure congestive—Etoposide—brain cancer	0.000947	0.00334	CcSEcCtD
Trazodone—SLC6A4—head—brain cancer	0.000946	0.00512	CbGeAlD
Trazodone—ADRA2A—telencephalon—brain cancer	0.000946	0.00512	CbGeAlD
Trazodone—Hallucination—Hydroxyurea—brain cancer	0.000945	0.00334	CcSEcCtD
Trazodone—HTR1A—spinal cord—brain cancer	0.000945	0.00511	CbGeAlD
Trazodone—Loss of consciousness—Procarbazine—brain cancer	0.000939	0.00331	CcSEcCtD
Trazodone—HTR2B—head—brain cancer	0.000938	0.00507	CbGeAlD
Trazodone—Hypertension—Procarbazine—brain cancer	0.000923	0.00326	CcSEcCtD
Trazodone—HTR2C—central nervous system—brain cancer	0.000911	0.00493	CbGeAlD
Trazodone—Myalgia—Procarbazine—brain cancer	0.00091	0.00321	CcSEcCtD
Trazodone—Arthralgia—Procarbazine—brain cancer	0.00091	0.00321	CcSEcCtD
Trazodone—Anxiety—Procarbazine—brain cancer	0.000907	0.0032	CcSEcCtD
Trazodone—HTR2A—brainstem—brain cancer	0.000906	0.0049	CbGeAlD
Trazodone—Dry mouth—Procarbazine—brain cancer	0.00089	0.00314	CcSEcCtD
Trazodone—Confusional state—Procarbazine—brain cancer	0.000879	0.0031	CcSEcCtD
Trazodone—Vomiting—Lomustine—brain cancer	0.000873	0.00308	CcSEcCtD
Trazodone—Oedema—Procarbazine—brain cancer	0.000872	0.00308	CcSEcCtD
Trazodone—SLC6A4—central nervous system—brain cancer	0.000864	0.00467	CbGeAlD
Trazodone—Shock—Procarbazine—brain cancer	0.000858	0.00303	CcSEcCtD
Trazodone—Pollakiuria—Temozolomide—brain cancer	0.000857	0.00302	CcSEcCtD
Trazodone—HTR2B—central nervous system—brain cancer	0.000856	0.00463	CbGeAlD
Trazodone—Erectile dysfunction—Temozolomide—brain cancer	0.000854	0.00301	CcSEcCtD
Trazodone—Chills—Hydroxyurea—brain cancer	0.000852	0.00301	CcSEcCtD
Trazodone—Tachycardia—Procarbazine—brain cancer	0.000851	0.003	CcSEcCtD
Trazodone—HTR1A—endocrine gland—brain cancer	0.000851	0.0046	CbGeAlD
Trazodone—Photosensitivity reaction—Temozolomide—brain cancer	0.000846	0.00299	CcSEcCtD
Trazodone—Weight increased—Temozolomide—brain cancer	0.000844	0.00298	CcSEcCtD
Trazodone—Hyperhidrosis—Procarbazine—brain cancer	0.000843	0.00298	CcSEcCtD
Trazodone—HTR1A—head—brain cancer	0.00084	0.00454	CbGeAlD
Trazodone—Alopecia—Hydroxyurea—brain cancer	0.00084	0.00296	CcSEcCtD
Trazodone—Weight decreased—Temozolomide—brain cancer	0.000839	0.00296	CcSEcCtD
Trazodone—Anorexia—Procarbazine—brain cancer	0.000831	0.00293	CcSEcCtD
Trazodone—CYP2D6—brainstem—brain cancer	0.000825	0.00446	CbGeAlD
Trazodone—Cardiac arrest—Etoposide—brain cancer	0.000816	0.00288	CcSEcCtD
Trazodone—Nausea—Lomustine—brain cancer	0.000816	0.00288	CcSEcCtD
Trazodone—Hypotension—Procarbazine—brain cancer	0.000815	0.00288	CcSEcCtD
Trazodone—HTR2A—telencephalon—brain cancer	0.000804	0.00435	CbGeAlD
Trazodone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000795	0.0028	CcSEcCtD
Trazodone—ADRA2A—gonad—brain cancer	0.000789	0.00427	CbGeAlD
Trazodone—Insomnia—Procarbazine—brain cancer	0.000789	0.00278	CcSEcCtD
Trazodone—ADRA1A—endocrine gland—brain cancer	0.000784	0.00424	CbGeAlD
Trazodone—Paraesthesia—Procarbazine—brain cancer	0.000783	0.00276	CcSEcCtD
Trazodone—Somnolence—Procarbazine—brain cancer	0.000775	0.00274	CcSEcCtD
Trazodone—ADRA1A—head—brain cancer	0.000774	0.00419	CbGeAlD
Trazodone—Perphenazine—CYP2C9—brain cancer	0.00077	0.112	CrCbGaD
Trazodone—ADRA2A—pituitary gland—brain cancer	0.00077	0.00416	CbGeAlD
Trazodone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000767	0.00271	CcSEcCtD
Trazodone—HTR1A—central nervous system—brain cancer	0.000767	0.00415	CbGeAlD
Trazodone—Anaemia—Hydroxyurea—brain cancer	0.000764	0.0027	CcSEcCtD
Trazodone—Hallucination—Carmustine—brain cancer	0.000764	0.0027	CcSEcCtD
Trazodone—Hypoaesthesia—Carmustine—brain cancer	0.000764	0.0027	CcSEcCtD
Trazodone—Decreased appetite—Procarbazine—brain cancer	0.000758	0.00268	CcSEcCtD
Trazodone—Fatigue—Procarbazine—brain cancer	0.000752	0.00265	CcSEcCtD
Trazodone—HTR1A—cerebellum—brain cancer	0.000749	0.00405	CbGeAlD
Trazodone—Malaise—Hydroxyurea—brain cancer	0.000746	0.00263	CcSEcCtD
Trazodone—Constipation—Procarbazine—brain cancer	0.000746	0.00263	CcSEcCtD
Trazodone—Pain—Procarbazine—brain cancer	0.000746	0.00263	CcSEcCtD
Trazodone—ADRA2A—medulla oblongata—brain cancer	0.000743	0.00402	CbGeAlD
Trazodone—Visual impairment—Carmustine—brain cancer	0.00074	0.00261	CcSEcCtD
Trazodone—Hallucination—Temozolomide—brain cancer	0.000738	0.00261	CcSEcCtD
Trazodone—Hypoaesthesia—Temozolomide—brain cancer	0.000738	0.00261	CcSEcCtD
Trazodone—CYP2D6—telencephalon—brain cancer	0.000732	0.00396	CbGeAlD
Trazodone—HTR2C—brain—brain cancer	0.000723	0.00391	CbGeAlD
Trazodone—Feeling abnormal—Procarbazine—brain cancer	0.000719	0.00254	CcSEcCtD
Trazodone—Visual impairment—Temozolomide—brain cancer	0.000715	0.00252	CcSEcCtD
Trazodone—Gastrointestinal pain—Procarbazine—brain cancer	0.000713	0.00252	CcSEcCtD
Trazodone—Flushing—Carmustine—brain cancer	0.000713	0.00252	CcSEcCtD
Trazodone—ADRA1A—central nervous system—brain cancer	0.000707	0.00382	CbGeAlD
Trazodone—Discomfort—Hydroxyurea—brain cancer	0.000696	0.00246	CcSEcCtD
Trazodone—Urticaria—Procarbazine—brain cancer	0.000693	0.00245	CcSEcCtD
Trazodone—Tinnitus—Temozolomide—brain cancer	0.000692	0.00244	CcSEcCtD
Trazodone—ADRA1A—cerebellum—brain cancer	0.000691	0.00374	CbGeAlD
Trazodone—Abdominal pain—Procarbazine—brain cancer	0.000689	0.00243	CcSEcCtD
Trazodone—Body temperature increased—Procarbazine—brain cancer	0.000689	0.00243	CcSEcCtD
Trazodone—Flushing—Temozolomide—brain cancer	0.000689	0.00243	CcSEcCtD
Trazodone—Arrhythmia—Carmustine—brain cancer	0.000686	0.00242	CcSEcCtD
Trazodone—SLC6A4—brain—brain cancer	0.000686	0.00371	CbGeAlD
Trazodone—HTR2B—brain—brain cancer	0.000679	0.00368	CbGeAlD
Trazodone—ADRA2A—midbrain—brain cancer	0.000679	0.00367	CbGeAlD
Trazodone—Alopecia—Carmustine—brain cancer	0.000679	0.0024	CcSEcCtD
Trazodone—Oedema—Hydroxyurea—brain cancer	0.000675	0.00238	CcSEcCtD
Trazodone—HTR2A—gonad—brain cancer	0.000671	0.00363	CbGeAlD
Trazodone—Chills—Temozolomide—brain cancer	0.000666	0.00235	CcSEcCtD
Trazodone—ADRA2A—spinal cord—brain cancer	0.000663	0.00358	CbGeAlD
Trazodone—Alopecia—Temozolomide—brain cancer	0.000656	0.00231	CcSEcCtD
Trazodone—HTR2A—pituitary gland—brain cancer	0.000655	0.00354	CbGeAlD
Trazodone—Acute coronary syndrome—Etoposide—brain cancer	0.000652	0.0023	CcSEcCtD
Trazodone—Clozapine—CYP2C9—brain cancer	0.00065	0.0943	CrCbGaD
Trazodone—Myocardial infarction—Etoposide—brain cancer	0.000648	0.00229	CcSEcCtD
Trazodone—Back pain—Carmustine—brain cancer	0.000647	0.00228	CcSEcCtD
Trazodone—Jaundice—Etoposide—brain cancer	0.000645	0.00228	CcSEcCtD
Trazodone—Anorexia—Hydroxyurea—brain cancer	0.000643	0.00227	CcSEcCtD
Trazodone—Hypersensitivity—Procarbazine—brain cancer	0.000643	0.00227	CcSEcCtD
Trazodone—Dysgeusia—Temozolomide—brain cancer	0.000633	0.00223	CcSEcCtD
Trazodone—HTR2A—medulla oblongata—brain cancer	0.000632	0.00342	CbGeAlD
Trazodone—Vision blurred—Carmustine—brain cancer	0.00063	0.00222	CcSEcCtD
Trazodone—Tremor—Carmustine—brain cancer	0.000626	0.00221	CcSEcCtD
Trazodone—Asthenia—Procarbazine—brain cancer	0.000626	0.00221	CcSEcCtD
Trazodone—CYP3A5—endocrine gland—brain cancer	0.000626	0.00338	CbGeAlD
Trazodone—Back pain—Temozolomide—brain cancer	0.000625	0.00221	CcSEcCtD
Trazodone—Anaemia—Carmustine—brain cancer	0.000618	0.00218	CcSEcCtD
Trazodone—Pruritus—Procarbazine—brain cancer	0.000617	0.00218	CcSEcCtD
Trazodone—Agitation—Carmustine—brain cancer	0.000614	0.00217	CcSEcCtD
Trazodone—Vision blurred—Temozolomide—brain cancer	0.000609	0.00215	CcSEcCtD
Trazodone—HTR1A—brain—brain cancer	0.000609	0.00329	CbGeAlD
Trazodone—HRH1—endocrine gland—brain cancer	0.000607	0.00328	CbGeAlD
Trazodone—Tremor—Temozolomide—brain cancer	0.000605	0.00214	CcSEcCtD
Trazodone—Dyspnoea—Hydroxyurea—brain cancer	0.000602	0.00212	CcSEcCtD
Trazodone—Somnolence—Hydroxyurea—brain cancer	0.0006	0.00212	CcSEcCtD
Trazodone—Ill-defined disorder—Temozolomide—brain cancer	0.000599	0.00212	CcSEcCtD
Trazodone—HRH1—head—brain cancer	0.000599	0.00324	CbGeAlD
Trazodone—Anaemia—Temozolomide—brain cancer	0.000597	0.00211	CcSEcCtD
Trazodone—Diarrhoea—Procarbazine—brain cancer	0.000597	0.00211	CcSEcCtD
Trazodone—ADRA2A—endocrine gland—brain cancer	0.000596	0.00323	CbGeAlD
Trazodone—Agitation—Temozolomide—brain cancer	0.000594	0.0021	CcSEcCtD
Trazodone—Hypoaesthesia—Etoposide—brain cancer	0.000591	0.00209	CcSEcCtD
Trazodone—ADRA2A—head—brain cancer	0.000589	0.00319	CbGeAlD
Trazodone—Decreased appetite—Hydroxyurea—brain cancer	0.000587	0.00207	CcSEcCtD
Trazodone—Malaise—Temozolomide—brain cancer	0.000583	0.00206	CcSEcCtD
Trazodone—Fatigue—Hydroxyurea—brain cancer	0.000582	0.00205	CcSEcCtD
Trazodone—Vertigo—Temozolomide—brain cancer	0.00058	0.00205	CcSEcCtD
Trazodone—HTR2A—midbrain—brain cancer	0.000577	0.00312	CbGeAlD
Trazodone—Hypertension—Carmustine—brain cancer	0.000577	0.00204	CcSEcCtD
Trazodone—Pain—Hydroxyurea—brain cancer	0.000577	0.00204	CcSEcCtD
Trazodone—Constipation—Hydroxyurea—brain cancer	0.000577	0.00204	CcSEcCtD
Trazodone—Dizziness—Procarbazine—brain cancer	0.000577	0.00204	CcSEcCtD
Trazodone—Palpitations—Temozolomide—brain cancer	0.000571	0.00201	CcSEcCtD
Trazodone—Myalgia—Carmustine—brain cancer	0.000569	0.00201	CcSEcCtD
Trazodone—Chest pain—Carmustine—brain cancer	0.000569	0.00201	CcSEcCtD
Trazodone—Anxiety—Carmustine—brain cancer	0.000567	0.002	CcSEcCtD
Trazodone—HTR2A—spinal cord—brain cancer	0.000563	0.00305	CbGeAlD
Trazodone—ADRA1A—brain—brain cancer	0.000561	0.00304	CbGeAlD
Trazodone—Hypertension—Temozolomide—brain cancer	0.000558	0.00197	CcSEcCtD
Trazodone—Feeling abnormal—Hydroxyurea—brain cancer	0.000556	0.00196	CcSEcCtD
Trazodone—Vomiting—Procarbazine—brain cancer	0.000555	0.00196	CcSEcCtD
Trazodone—Flushing—Etoposide—brain cancer	0.000551	0.00195	CcSEcCtD
Trazodone—Confusional state—Carmustine—brain cancer	0.00055	0.00194	CcSEcCtD
Trazodone—Arthralgia—Temozolomide—brain cancer	0.00055	0.00194	CcSEcCtD
Trazodone—Myalgia—Temozolomide—brain cancer	0.00055	0.00194	CcSEcCtD
Trazodone—Rash—Procarbazine—brain cancer	0.00055	0.00194	CcSEcCtD
Trazodone—Dermatitis—Procarbazine—brain cancer	0.000549	0.00194	CcSEcCtD
Trazodone—Anxiety—Temozolomide—brain cancer	0.000548	0.00193	CcSEcCtD
Trazodone—HRH1—central nervous system—brain cancer	0.000547	0.00296	CbGeAlD
Trazodone—Headache—Procarbazine—brain cancer	0.000546	0.00193	CcSEcCtD
Trazodone—Oedema—Carmustine—brain cancer	0.000546	0.00193	CcSEcCtD
Trazodone—Discomfort—Temozolomide—brain cancer	0.000543	0.00192	CcSEcCtD
Trazodone—Dry mouth—Temozolomide—brain cancer	0.000538	0.0019	CcSEcCtD
Trazodone—ADRA2A—central nervous system—brain cancer	0.000537	0.00291	CbGeAlD
Trazodone—Body temperature increased—Hydroxyurea—brain cancer	0.000534	0.00188	CcSEcCtD
Trazodone—Chills—Etoposide—brain cancer	0.000533	0.00188	CcSEcCtD
Trazodone—Tachycardia—Carmustine—brain cancer	0.000533	0.00188	CcSEcCtD
Trazodone—Confusional state—Temozolomide—brain cancer	0.000532	0.00188	CcSEcCtD
Trazodone—Oedema—Temozolomide—brain cancer	0.000527	0.00186	CcSEcCtD
Trazodone—ABCB1—telencephalon—brain cancer	0.000527	0.00285	CbGeAlD
Trazodone—ADRA2A—cerebellum—brain cancer	0.000525	0.00284	CbGeAlD
Trazodone—Alopecia—Etoposide—brain cancer	0.000525	0.00185	CcSEcCtD
Trazodone—Anorexia—Carmustine—brain cancer	0.00052	0.00184	CcSEcCtD
Trazodone—Nausea—Procarbazine—brain cancer	0.000518	0.00183	CcSEcCtD
Trazodone—Hypotension—Carmustine—brain cancer	0.00051	0.0018	CcSEcCtD
Trazodone—Hyperhidrosis—Temozolomide—brain cancer	0.00051	0.0018	CcSEcCtD
Trazodone—HTR2A—endocrine gland—brain cancer	0.000507	0.00274	CbGeAlD
Trazodone—Dysgeusia—Etoposide—brain cancer	0.000506	0.00179	CcSEcCtD
Trazodone—Anorexia—Temozolomide—brain cancer	0.000503	0.00177	CcSEcCtD
Trazodone—HTR2A—head—brain cancer	0.000501	0.00271	CbGeAlD
Trazodone—Back pain—Etoposide—brain cancer	0.0005	0.00176	CcSEcCtD
Trazodone—Hypersensitivity—Hydroxyurea—brain cancer	0.000497	0.00175	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000497	0.00175	CcSEcCtD
Trazodone—Insomnia—Carmustine—brain cancer	0.000494	0.00174	CcSEcCtD
Trazodone—Paraesthesia—Carmustine—brain cancer	0.00049	0.00173	CcSEcCtD
Trazodone—Dyspnoea—Carmustine—brain cancer	0.000486	0.00172	CcSEcCtD
Trazodone—Somnolence—Carmustine—brain cancer	0.000485	0.00171	CcSEcCtD
Trazodone—Asthenia—Hydroxyurea—brain cancer	0.000484	0.00171	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00048	0.0017	CcSEcCtD
Trazodone—Ill-defined disorder—Etoposide—brain cancer	0.00048	0.00169	CcSEcCtD
Trazodone—Anaemia—Etoposide—brain cancer	0.000478	0.00169	CcSEcCtD
Trazodone—Insomnia—Temozolomide—brain cancer	0.000477	0.00168	CcSEcCtD
Trazodone—Decreased appetite—Carmustine—brain cancer	0.000474	0.00167	CcSEcCtD
Trazodone—Paraesthesia—Temozolomide—brain cancer	0.000473	0.00167	CcSEcCtD
Trazodone—Dyspnoea—Temozolomide—brain cancer	0.00047	0.00166	CcSEcCtD
Trazodone—CYP3A4—endocrine gland—brain cancer	0.000469	0.00254	CbGeAlD
Trazodone—Somnolence—Temozolomide—brain cancer	0.000469	0.00165	CcSEcCtD
Trazodone—Constipation—Carmustine—brain cancer	0.000467	0.00165	CcSEcCtD
Trazodone—Pain—Carmustine—brain cancer	0.000467	0.00165	CcSEcCtD
Trazodone—Malaise—Etoposide—brain cancer	0.000466	0.00165	CcSEcCtD
Trazodone—Vertigo—Etoposide—brain cancer	0.000464	0.00164	CcSEcCtD
Trazodone—CYP2D6—endocrine gland—brain cancer	0.000462	0.0025	CbGeAlD
Trazodone—Diarrhoea—Hydroxyurea—brain cancer	0.000462	0.00163	CcSEcCtD
Trazodone—Decreased appetite—Temozolomide—brain cancer	0.000458	0.00162	CcSEcCtD
Trazodone—HTR2A—central nervous system—brain cancer	0.000457	0.00247	CbGeAlD
Trazodone—CYP2D6—head—brain cancer	0.000456	0.00247	CbGeAlD
Trazodone—Fatigue—Temozolomide—brain cancer	0.000455	0.0016	CcSEcCtD
Trazodone—Loss of consciousness—Etoposide—brain cancer	0.000454	0.0016	CcSEcCtD
Trazodone—Pain—Temozolomide—brain cancer	0.000451	0.00159	CcSEcCtD
Trazodone—Constipation—Temozolomide—brain cancer	0.000451	0.00159	CcSEcCtD
Trazodone—Feeling abnormal—Carmustine—brain cancer	0.00045	0.00159	CcSEcCtD
Trazodone—HTR2A—cerebellum—brain cancer	0.000447	0.00242	CbGeAlD
Trazodone—Hypertension—Etoposide—brain cancer	0.000446	0.00158	CcSEcCtD
Trazodone—Dizziness—Hydroxyurea—brain cancer	0.000446	0.00158	CcSEcCtD
Trazodone—Gastrointestinal pain—Carmustine—brain cancer	0.000446	0.00157	CcSEcCtD
Trazodone—Chest pain—Etoposide—brain cancer	0.00044	0.00155	CcSEcCtD
Trazodone—ABCB1—gonad—brain cancer	0.00044	0.00238	CbGeAlD
Trazodone—Discomfort—Etoposide—brain cancer	0.000435	0.00153	CcSEcCtD
Trazodone—Feeling abnormal—Temozolomide—brain cancer	0.000435	0.00153	CcSEcCtD
Trazodone—HRH1—brain—brain cancer	0.000434	0.00235	CbGeAlD
Trazodone—Body temperature increased—Carmustine—brain cancer	0.000431	0.00152	CcSEcCtD
Trazodone—Abdominal pain—Carmustine—brain cancer	0.000431	0.00152	CcSEcCtD
Trazodone—Gastrointestinal pain—Temozolomide—brain cancer	0.000431	0.00152	CcSEcCtD
Trazodone—Vomiting—Hydroxyurea—brain cancer	0.000429	0.00151	CcSEcCtD
Trazodone—ABCB1—pituitary gland—brain cancer	0.000429	0.00232	CbGeAlD
Trazodone—ADRA2A—brain—brain cancer	0.000427	0.00231	CbGeAlD
Trazodone—Rash—Hydroxyurea—brain cancer	0.000426	0.0015	CcSEcCtD
Trazodone—Confusional state—Etoposide—brain cancer	0.000425	0.0015	CcSEcCtD
Trazodone—Dermatitis—Hydroxyurea—brain cancer	0.000425	0.0015	CcSEcCtD
Trazodone—CYP3A4—central nervous system—brain cancer	0.000423	0.00229	CbGeAlD
Trazodone—Headache—Hydroxyurea—brain cancer	0.000423	0.00149	CcSEcCtD
Trazodone—Urticaria—Temozolomide—brain cancer	0.000419	0.00148	CcSEcCtD
Trazodone—Abdominal pain—Temozolomide—brain cancer	0.000417	0.00147	CcSEcCtD
Trazodone—Body temperature increased—Temozolomide—brain cancer	0.000417	0.00147	CcSEcCtD
Trazodone—CYP2D6—central nervous system—brain cancer	0.000416	0.00225	CbGeAlD
Trazodone—ABCB1—medulla oblongata—brain cancer	0.000414	0.00224	CbGeAlD
Trazodone—Tachycardia—Etoposide—brain cancer	0.000412	0.00145	CcSEcCtD
Trazodone—Hyperhidrosis—Etoposide—brain cancer	0.000408	0.00144	CcSEcCtD
Trazodone—CYP2D6—cerebellum—brain cancer	0.000407	0.0022	CbGeAlD
Trazodone—Anorexia—Etoposide—brain cancer	0.000402	0.00142	CcSEcCtD
Trazodone—Hypersensitivity—Carmustine—brain cancer	0.000402	0.00142	CcSEcCtD
Trazodone—Nausea—Hydroxyurea—brain cancer	0.000401	0.00141	CcSEcCtD
Trazodone—Hypotension—Etoposide—brain cancer	0.000394	0.00139	CcSEcCtD
Trazodone—Asthenia—Carmustine—brain cancer	0.000391	0.00138	CcSEcCtD
Trazodone—Hypersensitivity—Temozolomide—brain cancer	0.000388	0.00137	CcSEcCtD
Trazodone—Paraesthesia—Etoposide—brain cancer	0.000379	0.00134	CcSEcCtD
Trazodone—ABCB1—midbrain—brain cancer	0.000378	0.00205	CbGeAlD
Trazodone—Asthenia—Temozolomide—brain cancer	0.000378	0.00134	CcSEcCtD
Trazodone—Dyspnoea—Etoposide—brain cancer	0.000376	0.00133	CcSEcCtD
Trazodone—Somnolence—Etoposide—brain cancer	0.000375	0.00132	CcSEcCtD
Trazodone—Diarrhoea—Carmustine—brain cancer	0.000373	0.00132	CcSEcCtD
Trazodone—Pruritus—Temozolomide—brain cancer	0.000373	0.00132	CcSEcCtD
Trazodone—ABCB1—spinal cord—brain cancer	0.000369	0.002	CbGeAlD
Trazodone—Decreased appetite—Etoposide—brain cancer	0.000367	0.00129	CcSEcCtD
Trazodone—Fatigue—Etoposide—brain cancer	0.000364	0.00128	CcSEcCtD
Trazodone—HTR2A—brain—brain cancer	0.000363	0.00196	CbGeAlD
Trazodone—Dizziness—Carmustine—brain cancer	0.000361	0.00127	CcSEcCtD
Trazodone—Pain—Etoposide—brain cancer	0.000361	0.00127	CcSEcCtD
Trazodone—Constipation—Etoposide—brain cancer	0.000361	0.00127	CcSEcCtD
Trazodone—Diarrhoea—Temozolomide—brain cancer	0.000361	0.00127	CcSEcCtD
Trazodone—Dizziness—Temozolomide—brain cancer	0.000349	0.00123	CcSEcCtD
Trazodone—Feeling abnormal—Etoposide—brain cancer	0.000348	0.00123	CcSEcCtD
Trazodone—Vomiting—Carmustine—brain cancer	0.000347	0.00122	CcSEcCtD
Trazodone—Gastrointestinal pain—Etoposide—brain cancer	0.000345	0.00122	CcSEcCtD
Trazodone—Rash—Carmustine—brain cancer	0.000344	0.00121	CcSEcCtD
Trazodone—Dermatitis—Carmustine—brain cancer	0.000344	0.00121	CcSEcCtD
Trazodone—Headache—Carmustine—brain cancer	0.000342	0.00121	CcSEcCtD
Trazodone—Vomiting—Temozolomide—brain cancer	0.000335	0.00118	CcSEcCtD
Trazodone—Urticaria—Etoposide—brain cancer	0.000335	0.00118	CcSEcCtD
Trazodone—Abdominal pain—Etoposide—brain cancer	0.000334	0.00118	CcSEcCtD
Trazodone—Body temperature increased—Etoposide—brain cancer	0.000334	0.00118	CcSEcCtD
Trazodone—Rash—Temozolomide—brain cancer	0.000332	0.00117	CcSEcCtD
Trazodone—ABCB1—endocrine gland—brain cancer	0.000332	0.0018	CbGeAlD
Trazodone—Dermatitis—Temozolomide—brain cancer	0.000332	0.00117	CcSEcCtD
Trazodone—CYP2D6—brain—brain cancer	0.000331	0.00179	CbGeAlD
Trazodone—Headache—Temozolomide—brain cancer	0.00033	0.00117	CcSEcCtD
Trazodone—ABCB1—head—brain cancer	0.000328	0.00177	CbGeAlD
Trazodone—Nausea—Carmustine—brain cancer	0.000324	0.00114	CcSEcCtD
Trazodone—Nausea—Temozolomide—brain cancer	0.000313	0.00111	CcSEcCtD
Trazodone—Hypersensitivity—Etoposide—brain cancer	0.000311	0.0011	CcSEcCtD
Trazodone—Asthenia—Etoposide—brain cancer	0.000303	0.00107	CcSEcCtD
Trazodone—ABCB1—central nervous system—brain cancer	0.000299	0.00162	CbGeAlD
Trazodone—Pruritus—Etoposide—brain cancer	0.000299	0.00105	CcSEcCtD
Trazodone—ABCB1—cerebellum—brain cancer	0.000293	0.00158	CbGeAlD
Trazodone—Diarrhoea—Etoposide—brain cancer	0.000289	0.00102	CcSEcCtD
Trazodone—Dizziness—Etoposide—brain cancer	0.000279	0.000985	CcSEcCtD
Trazodone—Vomiting—Etoposide—brain cancer	0.000268	0.000947	CcSEcCtD
Trazodone—Rash—Etoposide—brain cancer	0.000266	0.000939	CcSEcCtD
Trazodone—Dermatitis—Etoposide—brain cancer	0.000266	0.000938	CcSEcCtD
Trazodone—Headache—Etoposide—brain cancer	0.000264	0.000933	CcSEcCtD
Trazodone—Nausea—Etoposide—brain cancer	0.000251	0.000884	CcSEcCtD
Trazodone—ABCB1—brain—brain cancer	0.000238	0.00129	CbGeAlD
Trazodone—CYP3A7—Metabolism—ENO2—brain cancer	2.49e-05	0.000619	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—IDH1—brain cancer	2.49e-05	0.000618	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TRPC6—brain cancer	2.49e-05	0.000618	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—DLL1—brain cancer	2.46e-05	0.000611	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—DLL1—brain cancer	2.45e-05	0.000608	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GLI1—brain cancer	2.45e-05	0.000608	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SMO—brain cancer	2.44e-05	0.000607	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTCH1—brain cancer	2.44e-05	0.000607	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—VAV1—brain cancer	2.43e-05	0.000604	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—VAV1—brain cancer	2.43e-05	0.000603	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GLI2—brain cancer	2.42e-05	0.0006	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	2.38e-05	0.000592	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SUFU—brain cancer	2.37e-05	0.000588	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SUFU—brain cancer	2.36e-05	0.000587	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP2C9—brain cancer	2.35e-05	0.000584	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SUFU—brain cancer	2.32e-05	0.000576	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.3e-05	0.000571	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—GFAP—brain cancer	2.29e-05	0.000568	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—GFAP—brain cancer	2.28e-05	0.000566	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—IDH1—brain cancer	2.28e-05	0.000566	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.28e-05	0.000566	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GLI1—brain cancer	2.27e-05	0.000565	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—GFAP—brain cancer	2.24e-05	0.000556	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—PIK3CG—brain cancer	2.22e-05	0.000552	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP2C9—brain cancer	2.22e-05	0.00055	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	2.21e-05	0.00055	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—VAV1—brain cancer	2.21e-05	0.000549	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	2.21e-05	0.000548	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—VAV1—brain cancer	2.21e-05	0.000548	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HEY1—brain cancer	2.17e-05	0.000538	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—VAV1—brain cancer	2.16e-05	0.000537	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HEY1—brain cancer	2.16e-05	0.000537	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SUFU—brain cancer	2.16e-05	0.000535	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—DLL1—brain cancer	2.13e-05	0.000528	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HEY1—brain cancer	2.12e-05	0.000527	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—DLL1—brain cancer	2.12e-05	0.000527	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SHH—brain cancer	2.09e-05	0.000519	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—DLL1—brain cancer	2.08e-05	0.000517	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SHH—brain cancer	2.08e-05	0.000517	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—GFAP—brain cancer	2.08e-05	0.000516	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TRPC6—brain cancer	2.02e-05	0.000501	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—VAV1—brain cancer	2.01e-05	0.000499	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TRPC6—brain cancer	2.01e-05	0.000498	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.01e-05	0.000498	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	2e-05	0.000497	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—BSG—brain cancer	2e-05	0.000497	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTCH1—brain cancer	1.98e-05	0.000492	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SMO—brain cancer	1.98e-05	0.000492	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTCH1—brain cancer	1.97e-05	0.00049	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SMO—brain cancer	1.97e-05	0.00049	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HEY1—brain cancer	1.97e-05	0.00049	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ENO2—brain cancer	1.97e-05	0.000488	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.95e-05	0.000485	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—DLL1—brain cancer	1.93e-05	0.00048	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—BSG—brain cancer	1.88e-05	0.000468	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VAV1—brain cancer	1.86e-05	0.000463	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.85e-05	0.000458	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SHH—brain cancer	1.81e-05	0.000449	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.8e-05	0.000448	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SHH—brain cancer	1.8e-05	0.000448	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ENO2—brain cancer	1.8e-05	0.000447	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—PIK3CG—brain cancer	1.79e-05	0.000444	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	1.78e-05	0.000442	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SHH—brain cancer	1.77e-05	0.000439	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TRPC6—brain cancer	1.74e-05	0.000433	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TRPC6—brain cancer	1.74e-05	0.000432	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—IDH1—brain cancer	1.72e-05	0.000427	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTCH1—brain cancer	1.71e-05	0.000425	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SMO—brain cancer	1.71e-05	0.000425	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SMO—brain cancer	1.71e-05	0.000424	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTCH1—brain cancer	1.71e-05	0.000424	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TRPC6—brain cancer	1.71e-05	0.000424	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTCH1—brain cancer	1.68e-05	0.000416	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SMO—brain cancer	1.68e-05	0.000416	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SHH—brain cancer	1.64e-05	0.000408	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PIK3CG—brain cancer	1.62e-05	0.000403	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—IDH1—brain cancer	1.62e-05	0.000402	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.62e-05	0.000401	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HES1—brain cancer	1.6e-05	0.000398	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TRPC6—brain cancer	1.59e-05	0.000394	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOTCH2—brain cancer	1.59e-05	0.000394	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.58e-05	0.000392	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—IL2—brain cancer	1.57e-05	0.000389	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SMO—brain cancer	1.56e-05	0.000387	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTCH1—brain cancer	1.56e-05	0.000387	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.55e-05	0.000385	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—PIK3CG—brain cancer	1.55e-05	0.000384	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—PIK3CG—brain cancer	1.54e-05	0.000383	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.53e-05	0.000379	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.52e-05	0.000376	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	1.51e-05	0.000376	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VAV1—brain cancer	1.51e-05	0.000375	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VAV1—brain cancer	1.5e-05	0.000373	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SPP1—brain cancer	1.48e-05	0.000368	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP2C9—brain cancer	1.45e-05	0.00036	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL2—brain cancer	1.41e-05	0.00035	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	1.41e-05	0.000349	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CG—brain cancer	1.4e-05	0.000348	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CG—brain cancer	1.4e-05	0.000348	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	1.37e-05	0.000341	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOTCH2—brain cancer	1.37e-05	0.00034	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOTCH2—brain cancer	1.37e-05	0.000339	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ENO2—brain cancer	1.36e-05	0.000338	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	1.34e-05	0.000333	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IRS2—brain cancer	1.34e-05	0.000333	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—VEGFA—brain cancer	1.33e-05	0.00033	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VAV1—brain cancer	1.31e-05	0.000324	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VAV1—brain cancer	1.3e-05	0.000323	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HES1—brain cancer	1.3e-05	0.000323	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HES1—brain cancer	1.29e-05	0.000321	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ENO2—brain cancer	1.28e-05	0.000318	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VAV1—brain cancer	1.28e-05	0.000317	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	1.28e-05	0.000317	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—IL2—brain cancer	1.26e-05	0.000313	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.25e-05	0.000311	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	1.25e-05	0.000309	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PDGFRA—brain cancer	1.24e-05	0.000307	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BSG—brain cancer	1.23e-05	0.000306	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.23e-05	0.000306	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.000298	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SPP1—brain cancer	1.2e-05	0.000297	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VAV1—brain cancer	1.19e-05	0.000295	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—APC—brain cancer	1.18e-05	0.000294	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.000294	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000284	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL2—brain cancer	1.14e-05	0.000284	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL2—brain cancer	1.14e-05	0.000282	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HES1—brain cancer	1.12e-05	0.000279	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HES1—brain cancer	1.12e-05	0.000278	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HES1—brain cancer	1.1e-05	0.000273	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—IL2—brain cancer	1.09e-05	0.00027	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IRS2—brain cancer	1.09e-05	0.00027	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—IL2—brain cancer	1.08e-05	0.000269	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IRS2—brain cancer	1.08e-05	0.000268	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.08e-05	0.000268	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PDGFRA—brain cancer	1.07e-05	0.000265	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PDGFRA—brain cancer	1.07e-05	0.000265	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—IL2—brain cancer	1.06e-05	0.000264	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—IDH1—brain cancer	1.06e-05	0.000263	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	1.05e-05	0.00026	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SPP1—brain cancer	1.04e-05	0.000258	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SPP1—brain cancer	1.04e-05	0.000257	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HES1—brain cancer	1.02e-05	0.000254	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SPP1—brain cancer	1.02e-05	0.000252	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—brain cancer	1.01e-05	0.00025	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—IL2—brain cancer	9.89e-06	0.000246	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL2—brain cancer	9.87e-06	0.000245	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL2—brain cancer	9.85e-06	0.000245	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	9.73e-06	0.000241	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL2—brain cancer	9.67e-06	0.00024	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CG—brain cancer	9.59e-06	0.000238	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—APC—brain cancer	9.59e-06	0.000238	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CG—brain cancer	9.55e-06	0.000237	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—APC—brain cancer	9.55e-06	0.000237	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SPP1—brain cancer	9.44e-06	0.000234	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IRS2—brain cancer	9.39e-06	0.000233	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IRS2—brain cancer	9.36e-06	0.000233	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—RELA—brain cancer	9.24e-06	0.00023	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IRS2—brain cancer	9.19e-06	0.000228	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ERBB2—brain cancer	9.19e-06	0.000228	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CG—brain cancer	9.02e-06	0.000224	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL2—brain cancer	8.98e-06	0.000223	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—brain cancer	8.74e-06	0.000217	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—brain cancer	8.7e-06	0.000216	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IRS2—brain cancer	8.54e-06	0.000212	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ENO2—brain cancer	8.38e-06	0.000208	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—brain cancer	8.33e-06	0.000207	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CG—brain cancer	8.29e-06	0.000206	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APC—brain cancer	8.29e-06	0.000206	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APC—brain cancer	8.27e-06	0.000205	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CG—brain cancer	8.27e-06	0.000205	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CG—brain cancer	8.26e-06	0.000205	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CCND1—brain cancer	8.12e-06	0.000202	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APC—brain cancer	8.12e-06	0.000202	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	8.12e-06	0.000202	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CTNNB1—brain cancer	8.04e-06	0.0002	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—brain cancer	7.55e-06	0.000188	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	7.54e-06	0.000187	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APC—brain cancer	7.54e-06	0.000187	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—brain cancer	7.54e-06	0.000187	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RELA—brain cancer	7.5e-06	0.000186	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RELA—brain cancer	7.46e-06	0.000185	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ERBB2—brain cancer	7.45e-06	0.000185	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ERBB2—brain cancer	7.41e-06	0.000184	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—brain cancer	7.39e-06	0.000184	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—brain cancer	7.08e-06	0.000176	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—brain cancer	7.01e-06	0.000174	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—brain cancer	6.87e-06	0.000171	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—brain cancer	6.75e-06	0.000168	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—brain cancer	6.72e-06	0.000167	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CCND1—brain cancer	6.58e-06	0.000163	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CCND1—brain cancer	6.55e-06	0.000163	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CTNNB1—brain cancer	6.52e-06	0.000162	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—brain cancer	6.51e-06	0.000162	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CTNNB1—brain cancer	6.48e-06	0.000161	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RELA—brain cancer	6.48e-06	0.000161	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RELA—brain cancer	6.46e-06	0.00016	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—brain cancer	6.44e-06	0.00016	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—brain cancer	6.42e-06	0.000159	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—brain cancer	6.37e-06	0.000158	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RELA—brain cancer	6.34e-06	0.000157	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—brain cancer	6.3e-06	0.000156	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CG—brain cancer	6.24e-06	0.000155	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RELA—brain cancer	5.89e-06	0.000146	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CG—brain cancer	5.88e-06	0.000146	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—brain cancer	5.86e-06	0.000145	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—brain cancer	5.83e-06	0.000145	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—brain cancer	5.82e-06	0.000145	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—brain cancer	5.74e-06	0.000142	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—brain cancer	5.71e-06	0.000142	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—brain cancer	5.71e-06	0.000142	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CCND1—brain cancer	5.69e-06	0.000141	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—brain cancer	5.68e-06	0.000141	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CCND1—brain cancer	5.67e-06	0.000141	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—brain cancer	5.65e-06	0.00014	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CTNNB1—brain cancer	5.63e-06	0.00014	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CTNNB1—brain cancer	5.62e-06	0.00014	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CCND1—brain cancer	5.57e-06	0.000138	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	5.51e-06	0.000137	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—brain cancer	5.35e-06	0.000133	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—brain cancer	5.31e-06	0.000132	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—brain cancer	5.28e-06	0.000131	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—brain cancer	5.25e-06	0.00013	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CCND1—brain cancer	5.17e-06	0.000128	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—brain cancer	5.16e-06	0.000128	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—brain cancer	5.14e-06	0.000128	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	5.12e-06	0.000127	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—brain cancer	4.96e-06	0.000123	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—brain cancer	4.95e-06	0.000123	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—brain cancer	4.91e-06	0.000122	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—brain cancer	4.9e-06	0.000122	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—brain cancer	4.85e-06	0.000121	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—brain cancer	4.81e-06	0.000119	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—brain cancer	4.56e-06	0.000113	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—brain cancer	4.55e-06	0.000113	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—brain cancer	4.51e-06	0.000112	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—brain cancer	4.47e-06	0.000111	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—brain cancer	4.47e-06	0.000111	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—brain cancer	4.46e-06	0.000111	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—brain cancer	4.45e-06	0.000111	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—brain cancer	4.37e-06	0.000108	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—brain cancer	4.34e-06	0.000108	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—brain cancer	4.31e-06	0.000107	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—brain cancer	4.15e-06	0.000103	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—brain cancer	4.06e-06	0.000101	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CG—brain cancer	3.84e-06	9.54e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—brain cancer	3.75e-06	9.3e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—brain cancer	3.74e-06	9.28e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—brain cancer	3.67e-06	9.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—brain cancer	3.41e-06	8.46e-05	CbGpPWpGaD
